Recombinant human erythropoietin in severe anaemia: Issues of dosing and duration

Anaesthesia and Intensive Care

Volumn 34, Issue 6, 2006, Pages 793-796

  Charles, A ^a   Purtill, M ^a   Napolitano, L M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anaemia; Critical illness; Erythropoietin; Jehovah's witness

Indexed keywords

ASCORBIC ACID; FERRIC HYDROXIDE SUCROSE; FERROUS SULFATE; FOLIC ACID; RECOMBINANT ERYTHROPOIETIN;

ADENOID CYSTIC CARCINOMA; AGED; ANEMIA; ARTICLE; BIOPSY; BLOOD SALVAGE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEMODILUTION; HUMAN; IATROGENIC DISEASE; IRON THERAPY; JEHOVAH'S WITNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; SOFT PALATE; VITAMIN SUPPLEMENTATION;

EID: 33845886919     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0603400319     Document Type: Article

References (22)

1. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89:4248-4267.
2. Wang GL, Semenza GL. Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 1996; 2:156-162.
3. Corwin HL. Anaemia in the critically ill: the role of erythropoietin. Semin Haematol 2001; 38:24-32.
4. Von Ahsen N, Muller C, Serke S et al. Important role of nondiagnostic blood loss and blunted erthropoietic response in the anaemia of medical intensive care patients. Crit Care Med 1999; 27:2630-2639.
5. Rogier P, Zhang H, Leeman M et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23:159-162.
6. Krafte-Jacobs B, Levetown ML, Bray GL et al. Erythropoietin response to critical illness. Crit Care Med 1994; 22:821-826.
7. VanIperen CE, Gaillard CA, Kraaijenhagen RJ et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in ICU patients. Crit Care Med 2000; 28:2773-2778.
8. Hobisch-Hagen P, Wiedermann F, Mayr A et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001; 29:743-747.
9. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-1023.
10. Rasanayagam SR, Cooper GM. Two cases of severe post-partum anaemia in Jehovah's witnesses. Int J Obstet Anesth 1996; 5:203-205.
11. Rutherford CJ, Schneider TJ, Dempsey H et al. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med 1994; 96:139-145.
12. Feagan BG, Wong CJ, Kirkley A et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000; 133:845-854.
13. Corwin HL, Gettinger A, Rodriguez RM et al. Efficacy of recombinant human erythropoietin in the critically ill patient. A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350.
14. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T; EPO Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288:2827-2835.
15. Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A. Critical Care Clinical Trials Greek Group. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study. Crit Care 2005; 9:11508-11515.
16. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-2778.
17. Ferzli GS, Hurwitz JB, Fiorillo MA et al. Laparoscopic splenectomy in a Jehovah's Witness with profound anaemia. Surg Endosc 1997; 11:850-851.
18. Kunz J, Mahr R. Management of severe blood loss after tumor resection in a Jehovah's Witness. Gynakol Geburtshilfliche Rundsch 1995; 35:34-37.
19. Madura JA. Use of erythropoietin and parenteral iron dextran in a severely anemic Jehovah's Witness with colon cancer. Arch Surg 1993; 128:1168-1170.
20. Hansen E, Bechmann V, Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective? Transfus Apher Sci 2002; 27:153-157.
21. Ng T, Marx G, Littlewood T, Macdougall I. Recombinant erythropoietin in clinical practice. Postgrad Med Journal 2003; 79:367-376.
22. Casadevall N, Mayeux P. Pure red-cell aplasia and recombinant erythropoietin. N Engl J Med 2002; 346:1585.